Overview of issues pertaining to the manufacture, distribution, and use of antimicrobials in animals and other information relevant to animal antimicrobial use data collection in the United States

This paper provides condensed literature review and contextual information concerning antimicrobial use in animals and antimicrobial use data collection techniques. Information is summarized into the following topics: (I) antimicrobial use for animal growth promotion; (II) regulatory framework for approval of veterinary antimicrobials and feed additives in the United States; (III) animal health product manufacturing and distribution networks; (IV) existing estimates of animal antimicrobial use in the United States; (V) additional sources for animal use data in the United States; (VI) recommendations from international expert groups; (VII) animal antimicrobial use surveillance systems in other nations and (VIII) human use data collection systems in the United States.     

Impacts of animal science research on United States sheep production and predictions for the future

One hundred years ago, there were more than 48 million sheep in the United States. In 1910, they were valued at $4/head, with 43% of income coming from the sale of sheep, lambs, and meat and 57% coming from wool. Over the years, fluctuations in this ratio have challenged the breeder and researcher alike. By 2007, sheep numbers had declined to 6.2 million, with the average sheep shearing 3.4 kg of wool (representing <10% of income), 0.2 kg more than in 1909 but 0.5 kg less than fleeces in 1955. Sheep operations have declined by more than 170,000 in the past 40 yr. A cursory examination of this information might lead one to conclude that animal science research has made little impact on sheep production in the United States. On the contrary, lamb crops in the new millennium (range = 109 to 115%) are greater than those recorded in the 1920s (85 to 89%) and dressed lamb weights increased from 18 to 32 kg from 1940 to the present. In the past century, researchers conducted thousands of investigations, with progress reported in new, existing, and crossbreed evaluations, quantitative and molecular genetics, selection, nutrition, fiber, meat, hides, milk, growth, physiology, reproduction, endocrinology, management, behavior, the environment, disease, pharmacology, toxicology, and range, pasture, and forage utilization such that a vast amount of new information was accrued. Our understanding of sheep has benefited also from research conducted on other species, and vice versa. Many factors that have contributed to the decline in the sheep industry are not influenced easily by academic research (e.g., low per capita consumption of lamb meat, predation, reluctance to adopt new technologies, cost and availability of laborers with sheep-related skills, and fewer young people pursuing careers in agriculture). The size of the US sheep industry is expected to remain stable, with possible slow growth in the foreseeable future. To remain profitable, producers will take advantage of new (or previously unused) technologies, the desire of the public for things natural, domestic niche and international fiber markets, and the ability of the sheep to control noxious weeds and thrive in suboptimal ecosystems.     

EXTENSION EDUCATION SYMPOSIUM: The future of biosecurity and antimicrobial use in livestock production in the United States and the role of extension1

As the global population continues to grow, food needs will increase as well. The amount of land and other resources devoted to agriculture production is not expected to grow significantly, leading most to agree that the substantial increases in food production to meet food security needs will come through the development of technologies that improve production efficiency. Diseases are constant threats to efficiency in all segments of agriculture. In livestock production, many of the bacterial pathogens that infect food animals are controlled through the use of antimicrobials. Antimicrobials are currently used in the United States not only to treat specific diseases, but also as feed additives to prevent bacterial disease in general or to improve growth performance. In recent years, there have been several proposals in the United States, both at state and federal levels, aimed at curtailing or dramatically reducing the use antimicrobials as feed additives, creating a policy similar to that of the European Union. Here we review the current policies on antimicrobial use in the European Union and their impact on food animal production. In addition, we discuss the future of antimicrobial use in food animal production in the United States and the increasing role of biosecurity programs. Finally, we discuss the role of Cooperative Extension Service in creating improved biosecurity programs and extension programs that provide policy makers and voters information on modern food animal production practices and technologies so that policies and regulations are effective and appropriate.     

The regulatory status of xylazine for use in food-producing animals in the United States

Xylazine is commonly used in veterinary medicine as a tranquillizer or adjunct to surgical anaesthesia. Although its use is approved in companion animals and certain species of deer, xylazine remains unapproved for use in food-producing animals in the United States. This paper reviews existing toxicological and residue chemistry information on xylazine in food animals, particularly cattle, and discusses the regulatory status of the drug in the US, as well as the conclusions reached by the Joint FAO/WHO Expert Committee on Food Additives in its recent evaluation of xylazine.     

Survey of antimicrobial susceptibility testing practices of veterinary diagnostic laboratories in the United States

OBJECTIVE: To describe antimicrobial susceptibility testing practices of veterinary diagnostic laboratories in the United States and evaluate the feasibility of collating this information for the purpose of monitoring antimicrobial resistance in bacterial isolates from animals. DESIGN: Cross-sectional study. PROCEDURES: A questionnaire was mailed to veterinary diagnostic laboratories throughout the United States to identify those laboratories that conduct susceptibility testing. Nonrespondent laboratories were followed up through telephone contact and additional mailings. Data were gathered regarding methods of susceptibility testing, standardization of methods, data management, and types of isolates tested. RESULTS: Eighty-six of 113 (76%) laboratories responded to the survey, and 64 of the 86 (74%) routinely performed susceptibility testing on bacterial isolates from animals. Thirty-four of the 36 (94%) laboratories accredited by the American Association of Veterinary Laboratory Diagnosticians responded to the survey. Laboratories reported testing > 160,000 bacterial isolates/y. Fifty-one (88%) laboratories reported using the Kirby-Bauer disk diffusion test to evaluate antimicrobial susceptibility; this accounted for 65% of the isolates tested. Most (87%) laboratories used the NCCLS (National Committee for Clinical Laboratory Standards) documents for test interpretation. Seventy-five percent of the laboratories performed susceptibility testing on bacterial isolates only when they were potential pathogens. CONCLUSIONS: The veterinary diagnostic laboratories represent a comprehensive source of data that is not easily accessible in the United States. Variability in testing methods and data storage would present challenges for data aggregation, summary, and interpretation.     

The human health implication of the use of antimicrobial agents in animal feeds

Antimicrobials given in subtherapeutic levels in feed are credited with having contributed to lower cost of meat, milk and eggs. The practice often is associated with the acquisition of resistant enteric flora by the involved animals, and this may in turn contribute to the human reservoir of antimicrobial resistant coliforms and salmonellae. Associated farm workers may transiently acquire resistant flora and on rare occasions develop salmonellosis. Although irrefutable evidence of growth promotant properties of antibiotics in animal feed was provided 30 to 40 years ago, additional studies on mechanisms of the effect are presently needed. It may be possible to identify factors effective in promoting growth without deleterious effects on flora. A national surveillance programme of antimicrobial utilisation (both subtherapeutic and therapeutic) among food producing animals should be established. Molecular epidemiologic research efforts will need to be undertaken to establish whether genetic information of animal origin importantly contributes to the human environmental pool of antimicrobial resistance. In the meantime, it does not appear that the use of drugs as feed additives, while allowing their unrestricted use for therapy in both animals and persons, would favorably influence the problems of antimicrobial resistance of salmonellosis in human populations.     

The human health implication of the use of antimicrobial agents in animal feeds

Summary

Antimicrobials given in subtherapeutic levels in feed are credited with having contributed to lower cost of meat, milk and eggs. The practice often is associated with the acquisition of resistant enteric flora by the involved animals, and this may in turn contribute to the human reservoir of antimicrobial resistant coliforms and salmonellae. Associated farm workers may transiently acquire resistant flora and on rare occasions develop salmonellosis. Although irrefutable evidence of growth promotant properties of antibiotics in animal feed was provided 30 to 40 years ago, additional studies on mechanisms of the effect are presently needed. It may be possible to identify factors effective in promoting growth without deleterious effects on flora. A national surveillance programme of antimicrobial utilisation (both subtherapeutic and therapeutic) among food producing animals should be established. Molecular epidemiologic research efforts will need to be undertaken to establish whether genetic information of animal origin importantly contributes to the human environmental pool of antimicrobial resistance. In the meantime, it does not appear that the use of drugs as feed additives, while allowing their unrestricted use for therapy in both animals and persons, wouldfavorably influence the problems of antimicrobial resistance of salmonellosis in human populations.     

Perceptions of state public health officers and state veterinarians regarding risks of bioterrorism in the United States

OBJECTIVE:To assess perceptions of state public health officers and state veterinarians in the United States regarding the risks of bioterrorism and determine the degree of support provided for activities related to bioterrorism. DESIGN: Cross-sectional survey. SAMPLE POPULATION: State public health officers and state veterinarians. PROCEDURE: A questionnaire was sent between April and June 2001 to the state public health officer and state veterinarian in each of the 50 states and the District of Columbia. RESULTS: Perceptions of the risk of bioterrorism attacks were similar for state public health officers and state veterinarians. Veterinarians perceived the risks associated with foot-and-mouth disease and Newcastle disease to be higher than did physicians. State veterinarians perceived the risks associated with an anthrax hoax, brucellosis, and ricin toxicosis to be lower than did state public health officers. Risk posed by agents that affected animals exclusively was perceived to be higher than risk posed by agents that affected humans exclusively and zoonotic agents. Number of full-time-equivalent positions devoted to bioterrorism surveillance and percentage of the budget devoted to bioterrorism activities were significantly lower for offices run by state veterinarians than for offices run by state public health officers. State veterinarians were significantly less likely to have knowledge of bioterrorism incidents within their state or district than were state public health officers. CONCLUSIONS AND CLINICAL RELEVANCE: Provision of additional resources to state veterinarians and explicit integration of their expertise and surveillance capabilities may be important to effectively mitigate the risk of bioterrorism.     

Guidelines for development and application of aquatic animal health regulations and control programs. AVMA Aquaculture and Seafood Advisory Committee.

The creation of sound health regulations or disease control programs for any animal species is a complex endeavor. When the diverse stakeholder interests related to aquaculture are considered, this endeavor becomes daunting. The AVMA Aquaculture and Seafood Advisory Committee designed the following guidelines as a tool to assist aquatic animal health professionals who discuss potential regulations or control programs with government and industry entities. The guide focuses on determining whether a regulation or program is appropriate and, if so, developing a suitable and effective aquatic animal health plan. The Aquaculture and Seafood Advisory Committee was established in 1992 as an ad hoc committee of the AVMA Executive Board. The committee is composed of 9 veterinarians with diverse interests in aquaculture and seafood, and one non-veterinarian who represents the aquaculture industry. Participants from the USDA/APHIS and FDA serve as consultants to the Committee.